Late-breaking abstract submission deadline: 10 May 2024. For late-breaking abstracts, an abbreviated or placeholder abstract must be submitted online by the regular abstract deadline of 04 March 2024. You can find further details about late-breaking abstracts in the Call for Abstracts below.
This document gives full details on abstract regulations, abstract format, the selection process and how accepted abstracts will be presented, as well as the full list of topics and sub-topics. Accepted EACR 2024 abstracts will be published in an online supplement to the journal Molecular Oncology.
The Scientific Committee will make the selection of abstracts for oral and poster presentations and the presenting author will receive an email with the Scientific Committee's decision no later than 08 April 2024.
Present your research
Multiple proffered paper slots in the main Congress programme
'Top Abstracts' session dedicated especially to proffered papers
Moderated 'Posters in the Spotlight' session for selected presenters to give a 5-minute presentation
Poster session with dedicated poster defence times during the Congress
e-poster galleries with recorded clips accompanying each PDF e-poster, available on the Congress website
Digital abstract gallery
Abstract Submission Deadline 04 March 2024
Travel Grant Application Deadline 04 March 2024
Early Rate Registration Deadline 29 April 2024
Late-Breaking Abstract Deadline (placeholder abstracts must be submitted by 04 March) 10 May 2024
Regular Rate Registration Deadline 27 May 2024
Above: A record number of 1,152 poster abstracts were presented at the EACR 2023 Annual Congress, covering a wide range of cancer research topics.
The EACR is a registered charity in England and Wales (1171827) and a company limited by guarantee (07682372). VAT number: 152897084. Registered address: Sir Colin Campbell Building, University of Nottingham Innovation Park, Triumph Road, Nottingham, NG72TU, UK.